Buys | $102,400 | 1 | 100 |
Sells | $0 | 0 | 0 |
Berg Aaron | President and CEO | 1 | $102,400 | 0 | $0 | $102,400 |
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with …
Over the last 12 months, insiders at Amarin Corporation plc have bought $102,400 and sold $0 worth of Amarin Corporation plc stock.
On average, over the past 5 years, insiders at Amarin Corporation plc have bought $174,734 and sold $5.19M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Berg Aaron (President and CEO) — $102,400.
The last purchase of 160,000 shares for transaction amount of $102,400 was made by Berg Aaron (President and CEO) on 2024‑08‑02.
2024-08-02 | Berg Aaron | President and CEO | 160,000 0.0389% | $0.64 | $102,400 | -10.08% | ||
2024-01-22 | Holt Patrick | President and CEO | 14,426 0.0033% | $1.09 | $15,724 | -39.29% | ||
2023-12-12 | Sale | Ketchum Steven B | Chief Scientific Officer | 34,131 0.0084% | $0.79 | $26,963 | -0.54% | |
2023-08-16 | Holt Patrick | President and CEO | 300,000 0.0723% | $1.04 | $312,315 | -18.77% | ||
2022-06-13 | WOLD OLSEN PER | 55,000 0.0137% | $1.69 | $92,730 | -21.76% | |||
2021-12-15 | Zakrzewski Joseph S | director | 2,000 0.0005% | $3.15 | $6,310 | -52.31% | ||
2021-12-14 | Zakrzewski Joseph S | director | 10,000 0.0025% | $3.27 | $32,689 | -52.00% | ||
2021-08-12 | Sale | Kalb Michael Wayne | SVP and CFO | 120,000 0.0282% | $5.25 | $630,240 | -41.05% | |
2021-06-04 | STACK DAVID M | director | 10,000 0.0026% | $4.54 | $45,350 | -17.42% | ||
2021-06-03 | STACK DAVID M | director | 5,000 0.0013% | $4.62 | $23,115 | -19.61% | ||
2021-02-01 | Sale | Ketchum Steven B | Chief Scientific Officer | 435,456 0.11% | $8.06 | $3.51M | -39.85% | |
2021-01-27 | Sale | Ketchum Steven B | Chief Scientific Officer | 843,258 0.2332% | $8.01 | $6.76M | -33.52% | |
2020-11-30 | STACK DAVID M | director | 50,000 0.0125% | $4.86 | $243,035 | +1.61% | ||
2020-11-11 | Sale | THERO JOHN F | President and CEO | 827,130 0.2094% | $4.07 | $3.36M | +22.63% | |
2020-11-10 | Sale | THERO JOHN F | President and CEO | 307,680 0.0792% | $4.13 | $1.27M | +22.63% | |
2020-03-04 | Sale | THERO JOHN F | President and CEO | 400,000 0.1106% | $15.99 | $6.4M | -58.77% | |
2020-01-03 | Sale | Zakrzewski Joseph S | director | 600,000 0.0965% | $12.17 | $7.3M | -67.88% | |
2019-12-16 | Sale | Berg Aaron | CHIEF COMMERCIAL OFFICER | 86,506 0.02% | $19.03 | $1.65M | -70.15% | |
2019-12-16 | Sale | Zakrzewski Joseph S | director | 200,000 0.0424% | $17.42 | $3.48M | -70.15% | |
2019-12-16 | Sale | Kalb Michael Wayne | SVP and CFO | 50,000 0.0142% | $23.36 | $1.17M | -70.15% |
Berg Aaron | President and CEO | 805380 0.1958% | $333,266.24 | 1 | 4 | |
THERO JOHN F | President and CEO | 2739000 0.666% | $1.13M | 6 | 9 | +65.82% |
Holt Patrick | President and CEO | 314426 0.0765% | $130,109.48 | 2 | 0 | <0.0001% |
Zakrzewski Joseph S | director | 196547 0.0478% | $81,331.15 | 3 | 16 | <0.0001% |
WOLD OLSEN PER | 149000 0.0362% | $61,656.20 | 1 | 0 | <0.0001% |
$2,924,567 | 72 | -4.87% | $157.74M | |
$613,304,943 | 46 | 11.85% | $191.55M | |
$48,218,096 | 42 | 0.89% | $204.72M | |
$79,019,806 | 27 | 7.24% | $165.26M | |
$6,915,275 | 21 | -32.61% | $158.47M |
Increased Positions | 55 | +26.57% | 10M | +15.69% |
Decreased Positions | 72 | -34.78% | 4M | -6.46% |
New Positions | 27 | New | 4M | New |
Sold Out Positions | 23 | Sold Out | 388,145 | Sold Out |
Total Postitions | 190 | -8.21% | 72M | +9.23% |
Sarissa Capital Management Lp | $13,469.00 | 6.05% | 24.85M | 0 | 0% | 2024-12-31 |
Kynam Capital Management, Lp | $6,729.00 | 3.02% | 12.41M | 0 | 0% | 2024-12-31 |
Morgan Stanley | $2,388.00 | 1.07% | 4.41M | +2M | +73.09% | 2024-12-31 |
Scp Investment, Lp | $1,355.00 | 0.61% | 2.5M | 0 | 0% | 2024-12-31 |
Waterfront Wealth Inc. | $1,345.00 | 0.6% | 2.48M | +2M | +181.44% | 2024-12-31 |
Two Sigma Investments, Lp | $1,178.00 | 0.53% | 2.17M | -206,279 | -8.67% | 2024-12-31 |
Acadian Asset Management Llc | $968.00 | 0.44% | 1.79M | +2M | +578.97% | 2024-12-31 |
Two Sigma Advisers, Lp | $943.00 | 0.42% | 1.74M | -236,700 | -11.98% | 2024-12-31 |
Longitude (Cayman) Ltd. | $878.00 | 0.39% | 1.62M | -750,000 | -31.65% | 2024-12-31 |
Eversept Partners, Lp | $822.00 | 0.37% | 1.52M | -2M | -54.17% | 2024-12-31 |